As pharma companies forge ahead, the need for agility and adaptability in change management becomes crucial for sustained growth. This discussion will explore the new structures and strategies necessary to thrive in this dynamic environment, addressing key questions such as who the decision-makers will be and how decisions will be made under redefined operating models. Join us to learn more about: 

• Transforming marketing frameworks within the pharmaceutical industry, focusing on the shift from traditional linear processes to more collaborative, cross-stakeholder models
• Embracing agile structures and strategies that allow for quick adaptation to changes in the market and organizational landscape
• Redefining decision-making roles and understanding the new leadership structure and how decisions will be made
• Aligning agile marketing models with sales realities to ensure strategies translate into actionable field execution, stronger customer conversations, and measurable commercial impact